Lyvelsa 20mg Tablet
By Lyvelsa
Rx
14 Tablet in a Strip

Composition
Finerenone(20mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
May, 2026

liver
Lyvelsa 20mg Tablet is generally considered safe for use in patients with liver disease. There is no need for a dose adjustment when taking this medication. However, if you have liver impairment or a history of liver disease, it is important to exercise caution. Before using Lyvelsa 20mg Tablet, be sure to inform your doctor about any existing liver conditions. Your doctor will evaluate the benefits and potential risks to determine if this medication is suitable for you. Remember to follow your healthcare provider's advice closely to ensure safe and effective use of Lyvelsa 20mg Tablet.

kidney
Lyvelsa 20mg Tablet is safe for use in patients with kidney disease, and no dose adjustment is needed. It can be taken safely as prescribed.

alcohol
Consult your doctor when consuming alcohol with Lyvelsa 20mg Tablet.

driving
It is not confirmed if Lyvelsa 20mg Tablet affects driving ability. Avoid driving if experiencing any concentration or reaction issues. Lyvelsa 20mg Tablet may induce weakness or tiredness in certain individuals, hence drive cautiously only when fully alert.

pregnancy
Lyvelsa 20mg Tablet is not recommended for use during pregnancy due to potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Consult your doctor before using this medication during pregnancy.

breastfeeding
Caution Lyvelsa 20mg Tablet should be used with caution during breastfeeding. It is advised to refrain from breastfeeding until the mother's treatment is over and the drug is cleared from her system. Avoid breastfeeding while on this medication as it may be harmful to your child.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹1495
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024